Tag: life sciences
-
NSF, Industry Group Fund Bio-Based Semiconductor R&D
A research consortium in the semiconductor industry and National Science Foundation are supporting a series of projects investigating interactions between biology and circuits for data transfer and storage.
-
Gates, Lauder Backing Early Alzheimer’s Biomarker Tests
A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up.
-
More Damage Detected from Crispr-Cas9 Edits
A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood.
-
A.I. Drug Discovery Company Gains $32M in Early Funds
A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round.
-
Exosome Technology Acquired for TBI, Stroke Therapies
A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes.
-
Wearables, Game App Help Boost Exercise Levels
A study assessing FitBit devices and a game-style mobile app shows a combination of the technologies results in more exercise by office workers, at least at the outset, than just the FitBit alone.
-
RNA Nanoparticles Designed for Brain Cancer Therapy
Medical researchers and material scientists devised a technique for delivering tiny particles of genetic material to the brain, which help lab mice shrink or remove their brain tumors and survive longer.
-
Trial Testing Vitamin D, Fatty Acids for Type 1 Diabetes
A clinical trial is underway testing vitamin D and omega-3 fatty acids in children and adults as a treatment for type 1 diabetes, the form of diabetes where the body does not produce insulin.
-
FDA Issues Draft Gene Therapy Regulatory Guidance
FDA issued a series of draft documents spelling out its processes for reviewing gene therapies for three types of diseases, as well as producing and testing these treatments.
-
Big Data, A.I. Applied to Precision Medicine for Lung Disease
A medical analytics company and two academic scientists are applying artificial intelligence technologies to discover precise therapies for people with idiopathic pulmonary fibrosis, a chronic lung disease.